Literature DB >> 16299786

Epidemiology of esophageal adenocarcinoma.

Manuel Pera1, Carlos Manterola, Oscar Vidal, Luis Grande.   

Abstract

The incidence of esophageal adenocarcinoma has risen rapidly over the past 25 years in the United States as well as in several Western European countries. This increase had been most dramatic among white males. The majority of these cancers arise from a background of premalignant Barrett esophagus. However, less than 10% of the patients with esophageal adenocarcinoma were known to have Barrett esophagus previously. It is uncertain which risk factors contribute to the increasing incidence of esophageal adenocarcinoma, although gastroesophageal reflux disease, cigarette smoking, and obesity have been implicated. Whereas infection with Helicobacter pylori and use of non-steroidal anti-inflammatory drugs are associated with reduced risk, low intakes of fruit, vegetables, and cereal fibers seem to increase the risk of esophageal adenocarcinoma. Presently there is no evidence that strongly supports any specific strategy to screen a subgroup of the population at risk for Barrett esophagus and adenocarcinoma of the esophagus. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2005        PMID: 16299786     DOI: 10.1002/jso.20357

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  89 in total

1.  Prague C&M and Japanese criteria: shades of Barrett's esophagus endoscopic diagnosis.

Authors:  Tetsu Kinjo; Chika Kusano; Ichiro Oda; Takuji Gotoda
Journal:  J Gastroenterol       Date:  2010-06-15       Impact factor: 7.527

Review 2.  Technological advances in radiotherapy for esophageal cancer.

Authors:  Milan Vosmik; Jiri Petera; Igor Sirak; Miroslav Hodek; Petr Paluska; Jiri Dolezal; Marcela Kopacova
Journal:  World J Gastroenterol       Date:  2010-11-28       Impact factor: 5.742

3.  Laparoscopic mediastinal dissection via an open left diaphragm approach for advanced Siewert type II adenocarcinoma.

Authors:  Shuji Takiguchi; Yasuhiro Miyazaki; Naoki Shinno; Tomoki Makino; Tsuyoshi Takahashi; Yukinori Kurokawa; Makoto Yamasaki; Kiyokazu Nakajima; Hiroshi Miyata; Masaki Mori; Yuichiro Doki
Journal:  Surg Today       Date:  2015-09-15       Impact factor: 2.549

4.  Laparoscopic lymphadenectomy around the left renal vein (16a2lat) by tunneling under the pancreas for advanced Siewert type II adenocarcinoma.

Authors:  Shuji Takiguchi; Yasuhiro Miyazaki; Kohei Murakami; Tomoki Makino; Tsuyoshi Takahashi; Yukinori Kurokawa; Makoto Yamasaki; Kiyokazu Nakajima; Hiroshi Miyata; Masaki Mori; Yuichiro Doki
Journal:  Surg Today       Date:  2015-10-19       Impact factor: 2.549

5.  MicroRNA prognostic signature for nodal metastases and survival in esophageal adenocarcinoma.

Authors:  Andrew Feber; Liqiang Xi; Arjun Pennathur; William E Gooding; Santhoshi Bandla; Maoxin Wu; James D Luketich; Tony E Godfrey; Virginia R Litle
Journal:  Ann Thorac Surg       Date:  2011-03-21       Impact factor: 4.330

6.  Interactions between environmental factors and polymorphisms in angiogenesis pathway genes in esophageal adenocarcinoma risk: a case-only study.

Authors:  Rihong Zhai; Yang Zhao; Geoffrey Liu; Monica Ter-Minassian; I-Chen Wu; Zhaoxi Wang; Li Su; Kofi Asomaning; Feng Chen; Matthew H Kulke; Xihong Lin; Rebecca S Heist; John C Wain; David C Christiani
Journal:  Cancer       Date:  2011-07-12       Impact factor: 6.860

7.  Towards an optimal treatment strategy for patients with oesophageal cancer.

Authors:  Javier Gallego Plazas; Vanesa Pons Sanz
Journal:  Clin Transl Oncol       Date:  2008-03       Impact factor: 3.405

8.  Effect of alpha-tocopherol, N-acetylcysteine and omeprazole on esophageal adenocarcinoma formation in a rat surgical model.

Authors:  Jing Hao; Bin Zhang; Ba Liu; Maojung Lee; Xingpei Hao; Kenneth R Reuhl; Xiaoxin Chen; Chung S Yang
Journal:  Int J Cancer       Date:  2009-03-15       Impact factor: 7.396

9.  Management of patients with T1b esophageal adenocarcinoma: a retrospective cohort study on patient management and risk of metastatic disease.

Authors:  Dirk Schölvinck; Hannah Künzli; Sybren Meijer; Kees Seldenrijk; Mark van Berge Henegouwen; Jacques Bergman; Bas Weusten
Journal:  Surg Endosc       Date:  2016-06-29       Impact factor: 4.584

10.  Diagnostic performance of diffusion-weighted magnetic resonance imaging in esophageal cancer.

Authors:  Aine Sakurada; Taro Takahara; Thomas C Kwee; Tomohiro Yamashita; Seiji Nasu; Tomohiko Horie; Marc Van Cauteren; Yutaka Imai
Journal:  Eur Radiol       Date:  2009-01-27       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.